ArticleFrontiers in nutrition2025
The relationship between changes in alcohol consumption and hepatic steatosis among alcohol consumers: a large-scale population-based Biobank study.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The relationship between changes in alcohol consumption and hepatic steatosis among alcohol consumers remains poorly understood. This study aimed to evaluate the association between changes in alcohol consumption and hepatic steatosis in a large population-based cohort of alcohol consumers. Methods: This study included 33,427 participants with reported alcohol consumption, categorized as mild, moderate, or heavy at baseline and imaging visits. Hepatic steatosis was assessed via magnetic resonance (MR) imaging during the imaging visit. Results: 9,131 (27.3%) participants were diagnosed with hepatic steatosis at imaging visit. After adjusting for confounders, mild drinkers who progressed to moderate (aOR 1.26, 95% CI 1.10-1.44) or heavy drinking (aOR 1.70, 95% CI 1.12-2.57) had elevated odds of hepatic steatosis compared to stable mild drinkers. Moderate drinkers who maintained moderate drinking (aOR 1.36, 95% CI 1.21-1.53) or progressed to heavy drinking (aOR 2.27, 95% CI 1.84-2.79) also showed increased risk compared to those who transitioned to mild drinking. Conversely, heavy drinkers who transitioned to moderate (aOR 0.58, 95% CI 0.47-0.72) or mild drinking (aOR 0.34, 95% CI 0.25-0.45) had significantly lower odds compared to stable heavy drinkers. Stratified analyses revealed that males, individuals under 65 years, those with higher BMI, and hypertensive patients were more susceptible to hepatic steatosis with increased alcohol consumption. Conclusion: Increasing alcohol intake raises the odds of hepatic steatosis, while reducing intake lowers the odds. Public health strategies should focus on decreasing alcohol consumption to alleviate the burden of hepatic steatosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.